Sophiris Bio, Inc.
SPHS
SPHS was delisted on the 11th of March, 2020.
29 hedge funds and large institutions have $2.47M invested in Sophiris Bio, Inc. in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 10 reducing their positions, and 2 closing their positions.
360% more call options, than puts
Call options by funds: $46K | Put options by funds: $10K
15% more capital invested
Capital invested by funds: $2.15M → $2.47M (+$324K)
6% less funds holding
Funds holding: 31 → 29 (-2)
80% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 10
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$36.6K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$23.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$43.8K |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$29.6K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$19.4K |
| 4 |
Two Sigma Investments
New York
|
-$17K |
| 5 |
VF
Virtu Financial
New York
|
-$12.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
APA
26
American Portfolios Advisors
Holbrook,
New York
| $990 | -$322 | -300 | -23% |
|
|
FDCDDQ
27
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $180 | – | – | – |
|
|
28
Two Sigma Investments
New York
| – | -$17K | -20,320 | Closed |
|
29
Wells Fargo
San Francisco,
California
| – | -$2K | -2,468 | Closed |
|
SPHS Hedge Fund Activity: Q1 2019 in Review
29 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Sophiris Bio, Inc. (SPHS) for Q1 2019, worth a combined $2.47M — up 15% from $2.15M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of SPHS and 0 opened new positions — a net loss of 2 holders — while 10 trimmed existing stakes and 2 added.
The largest buyer was Vanguard Group, adding an estimated $36.6K. The largest seller was Susquehanna International Group, cutting an estimated $43.8K.
- 29 institutional investors held Sophiris Bio, Inc. (SPHS) as of Q1 2019, down from 31 in Q4 2018.
- Funds reported $2.47M of Sophiris Bio, Inc. stock for Q1 2019, up 15% quarter-over-quarter.
- 0 funds opened new Sophiris Bio, Inc. positions in Q1 2019 and 2 closed out, a net change of -2 holders.
- The largest Sophiris Bio, Inc. buyer in Q1 2019 was Vanguard Group, an estimated $36.6K added.
- The largest Sophiris Bio, Inc. seller in Q1 2019 was Susquehanna International Group, an estimated $43.8K sold.
Based on aggregated 13F filings for Q1 2019.